Cargando…
Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database
BACKGROUND: The coronavirus disease 2019 (COVID-19) has become a worldwide public health crisis. At present, there are no effective antiviral drugs to treat COVID-19. Although some vaccines have been developed, late-stage clinical trials that allow licensure by regulatory agencies are still needed....
Autores principales: | Li, Zhonglin, Yang, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652993/ https://www.ncbi.nlm.nih.gov/pubmed/33193639 http://dx.doi.org/10.3389/fgene.2020.558557 |
Ejemplares similares
-
DMAP: a connectivity map database to enable identification of novel drug repositioning candidates
por: Huang, Hui, et al.
Publicado: (2015) -
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants
por: Iyer, Gayatri R., et al.
Publicado: (2020) -
Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases
por: Yang, Feng, et al.
Publicado: (2021) -
QTL Mapping and Identification of Candidate Genes for Heat Tolerance at the Flowering Stage in Rice
por: Chen, Lei, et al.
Publicado: (2021) -
Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates
por: Quan, Yuan, et al.
Publicado: (2019)